 | • レポートコード：D0SP21044 • 出版社/出版日：Transparency Market Research / 2020年8月31日 • レポート形態：英文、PDF、220ページ • 納品方法：Eメール • 産業分類：製薬 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ドライアイ疾患診断及び治療の世界市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、種類別（診断検査、治療）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ）分析、競争状況などの構成でお届けいたします。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・ドライアイ疾患診断及び治療の世界市場：種類別（診断検査、治療） ・ドライアイ疾患診断及び治療の世界市場：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ） ・競争状況 |
Dry Eye Disease Diagnostics & Treatment Market – Scope of the Report
TMR’s report on the global dry eye disease diagnostics & treatment market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the overall market revenue of the global dry eye disease diagnostics & treatment market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global dry eye disease diagnostics & treatment market for the forecast period.
The report has been prepared after extensive primary and secondary research. Primary research involves bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global dry eye disease diagnostics & treatment market.
Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomena in the global dry eye disease diagnostics & treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global dry eye disease diagnostics & treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global dry eye disease diagnostics & treatment market.
The report delves into the competition landscape of the global dry eye disease diagnostics & treatment market. Key players operating in the global dry eye disease diagnostics & treatment market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the global dry eye disease diagnostics & treatment market that have been profiled in this report.
Key Questions Answered in Dry Eye Disease Diagnostics & Treatment Market Report
What is the sales/revenue generated by each type and disease segment of the global dry eye disease diagnostics & treatment market across all regions during the forecast period?
What are the opportunities in the global dry eye disease diagnostics & treatment market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which region is likely to expand at the fastest CAGR during the forecast period?
Which dry eye disease diagnostics & treatment segments are expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
What is the market share or position of different companies operating in the global market in 2019?
Dry Eye Disease Diagnostics & Treatment Market – Research Objectives and Research Approach
The comprehensive report on the global dry eye disease diagnostics & treatment market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, pipeline analysis, key mergers & acquisitions, disease prevalence in key countries, technological advancements, and impact of COVID-19 in global dry eye disease diagnostics & treatment market have been provided.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into small sections. The entire report comprises an exhaustive collection of graphs and tables appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global dry eye disease diagnostics & treatment market in terms of type, disease, and region. Key segments under each criteria have been studied at length, and the market share for each of them at the end of 2030 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global dry eye disease diagnostics & treatment market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Dry Eye Disease Diagnostics & Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Technological Advancements
5.2. Pipeline Analysis
5.3. Disease Prevalence & Incidence Rate globally with key countries
5.4. Key Mergers & Acquisitions
5.5. COVID-19 Pandemics Impact on Industry (short / mid / long term impact)
6. Global Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2018–2030
6.3.1. Diagnostic Test
6.3.1.1. Schirmer’s Test
6.3.1.2. Corneal Staining
6.3.1.3. Tear Break-up Time (TBUT)
6.3.1.4. Optical Coherence Tomography (OCT)
6.3.1.5. Tear Film Stability Analysis
6.3.1.6. Tear Osmolarity
6.3.1.7. Others
6.3.2. Treatment
6.3.2.1. Artificial Tears
6.3.2.2. Anti-inflammatory
6.3.2.2.1. Cyclosporine
6.3.2.2.2. Corticosteroid
6.3.2.2.3. Others
6.3.2.3. Punctal Plugs
6.3.2.4. Secretagogue
6.3.2.5. Others
6.4. Market Attractiveness Analysis, by Type
7. Global Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast, by Disease
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Disease, 2018–2030
7.3.1. Evaporative Dry Eye Syndrome
7.3.2. Aqueous Dry Eye Syndrome
7.4. Market Attractiveness Analysis, by Disease
8. Global Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Country/Region
9. North America Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Type, 2018–2030
9.2.1. Diagnostic Test
9.2.1.1. Schirmer’s Test
9.2.1.2. Corneal Staining
9.2.1.3. Tear Break-up Time (TBUT)
9.2.1.4. Optical Coherence Tomography (OCT)
9.2.1.5. Tear Film Stability Analysis
9.2.1.6. Tear Osmolarity
9.2.1.7. Others
9.2.2. Treatment
9.2.2.1. Artificial Tears
9.2.2.2. Anti-inflammatory
9.2.2.2.1. Cyclosporine
9.2.2.2.2. Corticosteroid
9.2.2.2.3. Others
9.2.2.3. Punctal Plugs
9.2.2.4. Secretagogue
9.2.2.5. Others
9.3. Market Value Forecast, by Disease, 2018–2030
9.3.1. Evaporative Dry Eye Syndrome
9.3.2. Aqueous Dry Eye Syndrome
9.4. Market Value Forecast, by Country, 2018–2030
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Type
9.5.2. By Disease
9.5.3. By Country
10. Europe Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2018–2030
10.2.1. Diagnostic Test
10.2.1.1. Schirmer’s Test
10.2.1.2. Corneal Staining
10.2.1.3. Tear Break-up Time (TBUT)
10.2.1.4. Optical Coherence Tomography (OCT)
10.2.1.5. Tear Film Stability Analysis
10.2.1.6. Tear Osmolarity
10.2.1.7. Others
10.2.2. Treatment
10.2.2.1. Artificial Tears
10.2.2.2. Anti-inflammatory
10.2.2.2.1. Cyclosporine
10.2.2.2.2. Corticosteroid
10.2.2.2.3. Others
10.2.2.3. Punctal Plugs
10.2.2.4. Secretagogue
10.2.2.5. Others
10.3. Market Value Forecast, by Disease, 2018–2030
10.3.1. Evaporative Dry Eye Syndrome
10.3.2. Aqueous Dry Eye Syndrome
10.4. Market Value Forecast, by Country/Sub-region, 2018–2030
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Type
10.5.2. By Disease
10.5.3. By Country/Sub-region
11. Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2018–2030
11.2.1. Diagnostic Test
11.2.1.1. Schirmer’s Test
11.2.1.2. Corneal Staining
11.2.1.3. Tear Break-up Time (TBUT)
11.2.1.4. Optical Coherence Tomography (OCT)
11.2.1.5. Tear Film Stability Analysis
11.2.1.6. Tear Osmolarity
11.2.1.7. Others
11.2.2. Treatment
11.2.2.1. Artificial Tears
11.2.2.2. Anti-inflammatory
11.2.2.2.1. Cyclosporine
11.2.2.2.2. Corticosteroid
11.2.2.2.3. Others
11.2.2.3. Punctal Plugs
11.2.2.4. Secretagogue
11.2.2.5. Others
11.3. Market Value Forecast, by Disease, 2018–2030
11.3.1. Evaporative Dry Eye Syndrome
11.3.2. Aqueous Dry Eye Syndrome
11.4. Market Value Forecast, by Country/Sub-region, 2018–2030
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Type
11.5.2. By Disease
11.5.3. By Country/Sub-region
12. Latin America Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2018–2030
12.2.1. Diagnostic Test
12.2.1.1. Schirmer’s Test
12.2.1.2. Corneal Staining
12.2.1.3. Tear Break-up Time (TBUT)
12.2.1.4. Optical Coherence Tomography (OCT)
12.2.1.5. Tear Film Stability Analysis
12.2.1.6. Tear Osmolarity
12.2.1.7. Others
12.2.2. Treatment
12.2.2.1. Artificial Tears
12.2.2.2. Anti-inflammatory
12.2.2.2.1. Cyclosporine
12.2.2.2.2. Corticosteroid
12.2.2.2.3. Others
12.2.2.3. Punctal Plugs
12.2.2.4. Secretagogue
12.2.2.5. Others
12.3. Market Value Forecast, by Disease, 2018–2030
12.3.1. Evaporative Dry Eye Syndrome
12.3.2. Aqueous Dry Eye Syndrome
12.4. Market Value Forecast, by Country/Sub-region, 2018–2030
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Type
12.5.2. By Disease
12.5.3. By Country/Sub-region
13. Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2018–2030
13.2.1. Diagnostic Test
13.2.1.1. Schirmer’s Test
13.2.1.2. Corneal Staining
13.2.1.3. Tear Break-up Time (TBUT)
13.2.1.4. Optical Coherence Tomography (OCT)
13.2.1.5. Tear Film Stability Analysis
13.2.1.6. Tear Osmolarity
13.2.1.7. Others
13.2.2. Treatment
13.2.2.1. Artificial Tears
13.2.2.2. Anti-inflammatory
13.2.2.2.1. Cyclosporine
13.2.2.2.2. Corticosteroid
13.2.2.2.3. Others
13.2.2.3. Punctal Plugs
13.2.2.4. Secretagogue
13.2.2.5. Others
13.3. Market Value Forecast, by Disease, 2018–2030
13.3.1. Evaporative Dry Eye Syndrome
13.3.2. Aqueous Dry Eye Syndrome
13.4. Market Value Forecast, by Country/Sub-region, 2018–2030
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Type
13.5.2. By Disease
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share/Position Analysis, by Company, 2019
14.3. Competitive Business Strategies
14.4. Company Profiles
14.4.1. Novartis AG
14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.1.2. Company Financials
14.4.1.3. Growth Strategies
14.4.1.4. SWOT Analysis
14.4.2. Allergan plc
14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.2.2. Company Financials
14.4.2.3. Growth Strategies
14.4.2.4. SWOT Analysis
14.4.3. OASIS Medical
14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.3.2. Company Financials
14.4.3.3. Growth Strategies
14.4.3.4. SWOT Analysis
14.4.4. Santen Pharmaceutical Co., Ltd.
14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.4.2. Company Financials
14.4.4.3. Growth Strategies
14.4.4.4. SWOT Analysis
14.4.5. Johnson & Johnson
14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.5.2. Company Financials
14.4.5.3. Growth Strategies
14.4.5.4. SWOT Analysis
14.4.6. Otsuka Pharmaceutical Co., Ltd.
14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.6.2. Company Financials
14.4.6.3. Growth Strategies
14.4.6.4. SWOT Analysis
14.4.7. Advanced Tear Diagnostics
14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.7.2. Company Financials
14.4.7.3. Growth Strategies
14.4.7.4. SWOT Analysis
14.4.8. Tomey Corporation
14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.8.2. Company Financials
14.4.8.3. Growth Strategies
14.4.8.4. SWOT Analysis
14.4.9. Carl Zeiss Meditec AG
14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.9.2. Company Financials
14.4.9.3. Growth Strategies
14.4.9.4. SWOT Analysis
14.4.10. TearLab Corporation
14.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.10.2. Company Financials
14.4.10.3. Growth Strategies
14.4.10.4. SWOT Analysis
14.4.11. Bausch Health Companies, Inc.
14.4.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.11.2. Company Financials
14.4.11.3. Growth Strategies
14.4.11.4. SWOT Analysis
14.4.12. RegeneRx (ReGenTree, LLC)
14.4.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.12.2. Company Financials
14.4.12.3. Growth Strategies
14.4.12.4. SWOT Analysis
List of TablesTable 01: Global Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 02: Global Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Diagnostic Test, 2018–2030
Table 03: Global Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Treatment, 2018–2030
Table 04: Global Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030
Table 05: Global Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
Table 06: Global Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 07: North America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 08: North America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 09: North America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Diagnostic Test, 2018–2030
Table 10: North America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Treatment, 2018–2030
Table 11: North America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030
Table 12: North America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
Table 13: Europe Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 14: Europe Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 15: Europe Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Diagnostic Test, 2018–2030
Table 16: Europe Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Treatment, 2018–2030
Table 17: Europe Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030
Table 18: Europe Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
Table 19: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 20: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Type, 2018–2030
Table 21: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Diagnostic Test, 2018–2030
Table 22: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Treatment, 2018–2030
Table 23: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030
Table 24: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Disease, 2018–2030
Table 25: Latin America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 26: Latin America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 27: Latin America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Diagnostic Test, 2018–2030
Table 28: Latin America Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Treatment, 2018–2030
Table 29: Latin America Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030
Table 30: Latin America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
Table 31: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 32: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Type, 2018–2030
Table 33: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Diagnostic Test, 2018–2030
Table 34: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Treatment, 2018–2030
Table 35: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030
Table 36: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Disease, 2018–2030